Paolini John F.
CHIEF MEDICAL OFFICER
Paolini John F. has filed 7 SEC Form 4 filings (25 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Sep 3, 2026.
On the most recent filing, Paolini John F. is listed as CHIEF MEDICAL OFFICER at Kiniksa Pharmaceuticals International, plc. Inside the rolling window, Paolini John F. reported no open-market purchases and 3 open-market sales totaling $8.0M in KNSA. The largest disclosed transaction in the window is a sale of 58,424 KNSA shares on May 1, 2026, worth $3.1M.
Companies traded
Other insiders at KNSA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$8.0M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Paolini John F. made?
Paolini John F. has filed 7 SEC Form 4 filings (25 transaction rows) across 1 company since 2025.
Which companies does Paolini John F. trade?
Paolini John F. has filed SEC Form 4 disclosures for 1 company, including KNSA.
When was Paolini John F.'s most recent SEC Form 4 filing?
Paolini John F.'s most recent SEC Form 4 filing on Tracefour is dated Sep 3, 2026.
What is Paolini John F.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Paolini John F. is listed as CHIEF MEDICAL OFFICER.
What is Paolini John F.'s total buy and sell value in the current window?
Inside the rolling retention window, Paolini John F. bought $0 and sold $8.0M based on SEC Form 4 filings.
What was Paolini John F.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 58,424 KNSA shares on 2026-05-01, worth $3.1M, per SEC Form 4 filings.